Table 2.
Baseline clinical characteristics for 3503 patients with HCV cirrhosis by HCC status.
| No HCC | Developed HCC | P-value | |
|---|---|---|---|
| (n = 3265) | (n = 238) | ||
| Age | 54.2 ± 9.7 | 56.4 ± 9.4 | <0.001 |
| Sex (male) | 61.10% | 70.60% | 0.004 |
| Metabolic syndrome | 13.30% | 21.40% | <0.001 |
| Diabetes Type II | 26.30% | 40.80% | <0.001 |
| Hypertension | 40.50% | 56.70% | <0.001 |
| Hyperlipidemia | 12.10% | 13.90% | 0.420 |
| Body Mass Index | 29.0 ± 6.9 | 28.2 ± 5.5 | 0.110 |
| Coronary Artery Disease | 10.60% | 19.80% | <0.001 |
| Significant history alcohol use | 46.30% | 46.60% | 0.930 |
| Ethnicity | |||
| White | 50.30% | 51.30% | <0.001 |
| Asian | 21.20% | 27.70% | |
| Hispanic | 8.50% | 13.00% | |
| Other | 20.00% | 8.00% | |
| Child Pugh Score | |||
| A | 45.60% | 26.50% | <0.001 |
| BC | 54.40% | 73.50% | |
Abbreviations: HCC, hepatocellular carcinoma; HCV, hepatitis C virus.